ABSTRACT. Niemann-Pick type C (NP-C) disease is a devastating developmental disorder with progressive and fatal neurodegeneration. We have used a mouse model of Niemann-Pick type C (NP-C) disease to evaluate the effects of direct intracerebral transplantation of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) on the progression of neurological disease in this order. Here, we show that hUCB-MSCs transplantation into NP-C mice prevents the loss of Purkinje neurons and inhibits cerebellar apoptotic cell death. Interestingly, these effects were associated with the modulation of inflammatory responses, as evidenced by increased antiinflammatory cytokine IL-10, and reduced abnormal astrocytic activation. Furthermore, our results show that the hUCB-MSCs transplantation reduced the cholesterol accumulation level in neurons in NP-C mice compared with sham-transplanted animals. This study provides the first evidence that hUCB-MSCs can improve neurological symptoms in NP-C disease, suggesting it as a potential therapeutic agent against neurodegenerative diseases. Niemann-Pick Type C (NP-C) disease is a neurodegenerative autosomal recessive lysosomal storage disease, characterized by the accumulation of cholesterol and other lipids both in the periphery and in the brain [40] . Most cases are caused by loss-of-function mutations in NPC1 (95% of clinical cases) [9] , a gene encoding an integral membrane protein that participates in lipid trafficking from late endosomes/lysosomes into other subcellular compartments [35, 40] . NP-C has been studied in a number of models, the best characterized and most widely used of which is a mouse model in which a spontaneous insertion of a retrotransposon element into exon 9 of the NPC1 gene [9] . This model reproduces many aspects of the human disease, including cellular accumulations of unesterified cholesterol and glycosphingolipids [49, 52] . NPC1-deficient mice also exhibit systemic pathology including hepatosplenomegaly and develop a progressive neurodegeneration, characterized by abnormally swollen axons, demyelination, and progressive neuronal loss, most notably of cerebellar Purkinje neurons [17, 28, 52] . In addition, activation of inflammation is an early neuropathological event in NP-C. Reactive microglia and astrocytes could further contribute to the degenerative process by releasing a variety of neurotoxic cytokines [30] . These cellular defects in the NP-C mouse are accompanied by behavioral impairments paralleling the neurological and systemic symptoms of the human disorder, including abnormal gait and Rota-Rod performance, cognitive deficits, weight loss, and early death [41] .
Niemann-Pick Type C (NP-C) disease is a neurodegenerative autosomal recessive lysosomal storage disease, characterized by the accumulation of cholesterol and other lipids both in the periphery and in the brain [40] . Most cases are caused by loss-of-function mutations in NPC1 (95% of clinical cases) [9] , a gene encoding an integral membrane protein that participates in lipid trafficking from late endosomes/lysosomes into other subcellular compartments [35, 40] . NP-C has been studied in a number of models, the best characterized and most widely used of which is a mouse model in which a spontaneous insertion of a retrotransposon element into exon 9 of the NPC1 gene [9] . This model reproduces many aspects of the human disease, including cellular accumulations of unesterified cholesterol and glycosphingolipids [49, 52] . NPC1-deficient mice also exhibit systemic pathology including hepatosplenomegaly and develop a progressive neurodegeneration, characterized by abnormally swollen axons, demyelination, and progressive neuronal loss, most notably of cerebellar Purkinje neurons [17, 28, 52] . In addition, activation of inflammation is an early neuropathological event in NP-C. Reactive microglia and astrocytes could further contribute to the degenerative process by releasing a variety of neurotoxic cytokines [30] . These cellular defects in the NP-C mouse are accompanied by behavioral impairments paralleling the neurological and systemic symptoms of the human disorder, including abnormal gait and Rota-Rod performance, cognitive deficits, weight loss, and early death [41] .
To date, the stem cells transplantation therapies of the central nervous system (CNS) pathologies are promising therapeutic strategies for neurodegenerative diseases [12, 14, 16, 29, 36, 38] . Previously, our studies have shown that transplantation of bone marrow-derived mesenchymal stem cells (BM-MSCs) results in the alleviation of pathologies associated with murine NP-C cerebellums [2, 3] . MSCs are multipotent cells found in fetal liver, bone marrow, and umbilical cord blood [8, 13] . Although bone marrow is a major source of MSCs [43] , the limitations of using BMMSCs for stem-cell therapy, including the technical difficulty of bone marrow collection and the stringent requirements for autologous donors, have forced researchers to look for alternative sources of MSCs [31] . Human umbilical cord blood-derived mesenchymal stem cells (hUCBMSCs) have a number of advantages over BM-MSCs with respect to multi potency, availability, and accessibility, thus making hUCB-MSCs more suitable than BM-MSCs for clinical applications [21] . Furthermore, hUCB-MSCs retain low immunogenicity and an immunomodulatory effect [45] .
In this study, we assessed the therapeutic effects of hUCB-MSCs in a mouse model of NP-C disease (NPC1 deficient mice). Here we show that hUCB-MSCs prevented Purkinje neurons loss and inhibited cerebellar apoptotic cell death. The hUCB-MSCs transplanted NP-C mice exhibited increased levels of neuroprotective cytokine, decreased neuroglial activation and reduced cholesterol accumulation.
These results suggest that hUCB-MSCs may be a useful therapeutic agent against NP-C disease. ) has been maintained, by brother-sister mating of heterozygous animals. The genotype of each mouse was determined by PCR [27] . The animals were housed in a room maintained under controlled temperature conditions and on a circadian 12/12 hr light/dark cycle. In our experiments, we used only male mice. All procedures were in accordance with an animal protocol approved by the Kyungpook National University Institutional Animal Care and Use Committee (IACUC).
MATERIALS AND METHODS

Animals
Culturing of the hUCB-MSCs: We obtained hUCB-MSCs from Medipost Inc., Seoul, Korea (Human) UCB samples were collected from the umbilical vein of deliveries with informed maternal consent. In all cases, UCB harvests were processed within 24 hr of collection, with a viability of more than 90%. Cultures were maintained in -minimum essential medium (-MEM, Gibco BRL, Grand Island, NY U.S.A.), supplemented with a 10% (v/v) fetal bovine serum (FBS, Gibco). At 50% confluence, cells were harvested after treatment with 0.25% (w/v) trypsin-EDTA (Gibco) and were then reseeded for expansion. After the fifth passage, the cells were used for subsequent experiments. Differentiation characteristics of hUCB-MSCs, such as osteogenic, chondrogenic, and adipogenic differentiation were observed, as demonstrated from a previous study [51] .
Cell transplantation: NP-C mice (approximately 6 weeks of age, n=20 of each genotype) were anesthetized with a combination of 100 mg/kg ketamine and 10 mg/kg xylazine, and were then injected using the Styrofoam platform of a stereotaxic injection apparatus (Stoelting Co., Wood Dale, IL, U.S.A.) as described [3] . hUCB-MSCs which were labeled with nanoparticles (0.1 mg/ml, NFP-STEM Silanol TMSR-RITC 50, BITERIALS, Seoul, Korea), were transplanted into the cerebellum by use of a glass capillary (1.2  0.6 mm) [19] . The injection coordinates were 5.52 mm posterior to the bregma and the injection depth was 2.50 mm. The optimal cell number for transplantation was evaluated by injecting hUCB-MSCs with 1  the same transplantation procedure, but received a vehicle infusion of an equal volume of phosphate-buffered saline (PBS). After transplantation, the scalp was sutured closed. The animals were returned to their cages, after they recovered from anesthesia. Age-matched normal male littermates in the NP-C colony were used as controls.
Tissue preparation: The mice were sacrificed one week after the hUCB-MSCs transplantation procedure. The mice were anesthetized with 2.5% avertin in PBS. The animals were immediately cardiac perfused with 4% paraformaldehyde in PBS. After perfusion, their brains were removed, postfixed overnight at 4C, and incubated in 30 % sucrose at 4C until they were equilibrated. Sequential 12 and 30 m sagittal sections were taken on a cryostat (CM3050S; Leica, Wetzlar, Germany) and stored at -20C.
Histological analysis: Brain sections were incubated for 1 hr in PBS containing 5% normal goat serum, 2% BSA, and 0.4% Triton X-100. With the use of the same buffer solution, the sections were then incubated for 24 hr in primary antibodies at 4C. For the immunohistochemistry (IHC), we used primary antibodies, anti-calbindin-D 28K (rabbit, diluted 1:500; Chemicon, Temecula, CA, U.S.A. mouse, diluted 1:500; Abcam Cambridge, MA, U.S.A.), anti-GFAP (rabbit, diluted 1:500; Dako, Glostrup, Denmark), and antiactive caspase-3 (rabbit, diluted 1:200; Chemicon International). For visualization, the primary antibody was developed by incubating with Alexa Fluor 488-, 594-or 633-conjugated secondary antibodies for 1 hr at room temperature (RT) against the corresponding species (Molecular Probes, Carlsbad, CA, U.S.A.). We visualized cellular cholesterol using filipin (Polysciences, Warrington PA, U.S.A.), as previously described [42] . For sphingomyelin staining, an analysis was carried out, as previously described [50] . The sections were analyzed with a laser scanning confocal microscope equipped with Fluoview SV1000 imaging software (Olympus FV1000, Tokyo, Japan) or by a Olympus BX51 microscope. The images were then processed to enhance contrast and sharpness using Adobe Photoshop 6.0.
Quantitative real-time PCR: RNA extraction was performed with RNeasy Lipid Tissue Mini kit (Qiagen, Korea, Ltd.) according to the manufacturer's instructions. One week after transplantation, total RNA was extracted from the cerebellum. RNA samples from a total of three individual animals per group, in a different experiment, were used to prepare cDNA for reverse transcription polymerase chain reaction (RT-PCR) using the oligo (dT) [12] [13] [14] [15] [16] [17] [18] primers and SuperScript III RT (Invitrogen, Carlsbad, CA, U.S.A.). The cDNA was quantified using the QuantiTect SYBR Green PCR Kit (Qiagen, Korea, Ltd.). The PCR Primers used are described in Table 1 . For each investigated transcript, a mixture of the following reaction components was prepared to the indicated end-concentration: forward primer (5 pM), reverse primer (5 pM) and QuantiTect SYBR Green PCR Master mix. The 10 l master-mix was added to a 0.1 ml tube and also 5 l volume, containing 100 ng reverse transcribed total RNA, was added as the PCR template. The tubes were closed, centrifuged, and placed into the Corbett Research RG6000 real-time PCR machine. Each cycle consisted of 10 sec denaturation at 95C, 15 sec annealing at 58C, and 20 sec extension at 72C for 30 sec for 35 cycles after initial denaturation at 95C for 10 min. All reactions were performed in triplicate. The results were normalized using the -actin expression.
Accelerating the Rota-Rod analysis:
The Rota-Rod test assesses an animal's balance and coordination, by measuring the amount of time the animal is able to remain on a lon-gitudinally rotating rod. The Rota-Rod apparatus (accelerating model 47600; Ugo Basile, Comerio, VA, Italy) [11] has a 3 cm diameter rod, which is suitably machined to provide grip. In this apparatus, a motor sets the rotor in motion via the gear belt at a selected speed. When the mouse falls off its cylinder section, the plate below trips and the corresponding counter is disconnected, thereby recording the animal's endurance time in seconds. Use of an accelerating model ensures that screening results are less scattered [20] . Mice were placed on the rod at 4 rpm and monitored during acceleration of the rod to 40 rpm (5 min). Transplanted NP-C mice (n=5) were analyzed along with sham-transplanted NP-C (n=5), and normal control (transplanted WT n=5, sham-transplanted WT n=6) mice. Scores were registered every week (at least three independent tests were performed for each time point) beginning at 1 week after transplantation. Uniform conditions were carefully maintained for each test, and there was a rest time of 1 hr between trials. A maximum time limit of 5 min/test was established.
Statistical analysis: The Student's t-test was used to compare two groups, whereas the Tukey's HSD test and Measures Analysis of Variance test was used for multi-group comparisons according to the SAS statistical package (release 9.1; SAS Institute Inc., Cary, NC, U.S.A.). P<0.05 was considered to be significant.
RESULTS
hUCB-MSC transplantation prevents the loss of Purkinje neurons and inhibits cerebellar apoptotic cell death in NP-C mice:
The effects of the hUCB-MSCs on Purkinje neuron survival were assessed. The NP-C and WT mice were transplanted, in the cerebellum, with hUCB-MSCs at 6 weeks of age. One week after cell transplantation, Purkinje neurons were quantified by immunohistochemistry using calbindin antibodies. Figure 1A shows representative sections from transplanted NP-C (NP-C hUCB-MSCs TP) and agematched control (NP-C sham, WT hUCB-MSCs TP and WT sham) mice. Note the almost complete disappearance of Purkinje neurons and dendritic degeneration in the sham transplanted NP-C mice. In contrast, the number of surviving Purkinje neurons was increased substantially in the hUCB-MSCs transplanted NP-C group as compared to sham-transplanted NP-C mice. The greatest effect on the survival of Purkinje neurons was evident in lobes VII and VIII (Fig. 1B) . There were no differences in the hUCB-MSC transplanted WT mice as compared to sham-transplanted WT mice.
The hUCB-MSC treatment dramatically reduced the number of active caspase-3 immunoreactive cells in the cerebellums of NP-C mice (Fig. 1C) . At this same age, shamtreated NP-C mice had many active caspase-3 immunoreactive cells. A significant decrease of apoptotic cells from the use of the hUCB-MSC treatment was correlated with an increase in calbindin staining in the same slices.
The hUCB-MSC treatment increases the expression level of anti-inflammatory cytokine IL-10 in NP-C mice: Neurodegeneration in NP-C disease is accompanied by inflammation. The up-regulation of the pro-inflammatory pathways is a key feature of NP-C disease [47] . To evaluate the influence of hUCB-MSCs on the inflammatory immune responses in NP-C mice, we examined the expression of the several anti-inflammatory cytokines (IL-10, IL-4 and TGF-) and pro-inflammatory cytokines (IL-6, IL-1 and TNF-) mRNAs. The results revealed clear induction in the expression of IL-10 mRNA in the hUCB-MSC treated NP-C mice ( Fig. 2A, 2 .66-fold increased compared to the sham transplanted mice, P<0.05). There were no significant differences in expression of other anti-inflammatory cytokines observed between the groups, although we found slight increases in the hUCB-MSCs transplanted NP-C mice ( Fig.  2A) . The expressions of pro-inflammatory cytokines revealed no significant differences between the groups (Fig.  2B ). These data indicate that the hUCB-MSC treatment could modulate the inflammatory reactions by up-regulation of the anti-inflammatory cytokine expression in NP-C mice.
The hUCB-MSC reduces cholesterol accumulation and suppresses astrocytic activation in the cerebellum of NP-C mice:
We evaluated the effect of the hUCB-MSC transplantation on intracellular accumulation of cholesterol. Analysis of the cerebellar cortex from sham-transplanted NP-C mice revealed that nearly every Purkinje neuron, as well as cells in both the granule and molecular cell layer, showed evidence of cholesterol accumulation by filipin labeling (Fig.  3A) . However, most Purkinje neurons in the hUCB-MSC transplanted NP-C mice lacked cholesterol storage and only a small number of filipin positive cells were present in both the granule and molecular cell layer. In WT control sections, no cholesterol accumulation was observed. Analysis of sphingomyelin did not observe any detectable storage reductions between the transplanted group and the sham- transplanted group in NP-C mice. Astrocyte activation has been considered a key process leading to neuronal degeneration in NP-C mice [5] . To examine the effect of hUCBMSCs transplantation on astrocytic activation, we prepared sections from the cerebellums of NP-C mice with or without hUCB-MSC transplantation, and monitored astrocytic activation by GFAP staining. The results show that activated astrocytes appear in the cerebellar cortex of the sham-transplanted NP-C mice brains, but not those of the WT mice brains (Fig. 3B) . hUCB-MSCs transplantation of NP-C mice clearly decreased astrocyte activation in the cerebellar cortex (Fig. 3B) .
The hUCB-MSC treatment improves motor function in NP-C mice:
Motor dysfunction and ataxia were evident in the course of the degeneration of cerebellar Purkinje neurons in NP-C disease [44] . As mentioned above, our result showed that the total number of surviving Purkinje neurons were significantly increased in hUCB-MSC transplanted NP-C mice. Therefore, to further understand the contributions of hUCB-MSC transplantation to the improvement of pathology in NP-C mice, we studied the motor functional changes. The Rota-Rod test assesses an animal's balance and coordination by measuring the amount of time the animal is able to remain on a longitudinally rotating rod. Four groups of male mice were tested in three trials. Rota-Rod testing was conducted once a week until the mice died of natural causes. There were improvements in cerebellar function, as identified by Rota-Rod analysis, in the hUCB-MSC transplanted NP-C mice as compared to the shamtransplanted NP-C group (Fig. 4) . But the results did not reach statistical significance.
DISCUSSION
Neurodegenerative diseases are characterized by a progressive degeneration of selective neural populations [39] . The lack of effective treatments and the characteristics of their pathology make these diseases appropriate candidates for cell therapy. BM-MSCs have great therapeutic potential for neurological disease because of their self-renewal and multipotent differentiative capacity and their immunosuppressive function [39] . They have been used extensively for intracerebral engraftment in animal models of neurological disease [16, 19, 28, 36, 38] . However, bone marrow may be detrimental because of the highly invasive donation procedure and BM-MSCs decline number with increasing age [31] . Therefore, MSCs derived from other sources have been considered as an alternative. Among the sources of MSCs, hUCB-MSCs are promising candidates for developing cell therapies for neurodegenerative diseases because of its accessibility, the lack of risk to the mother or infant, and the fact that there is no problem with the ethical barrier. In addition, it is a painless procedure to donors and a promising source for autologous cell therapy [15] . In this study, we demonstrated that transplanted hUCB-MSCs improved survival of Purkinje neurons and inhibited cerebellar apoptotic cell death in NP-C mice (Fig. 1) . Previous studies have
shown that NP-C neurodegeneration is associated with an increase of apoptotic markers in the brains of NP-C mice and humans with NP-C disease [48] . In addition, it was shown that the loss of Purkinje neurons is primarily a cellautonomous defect in the mouse model of NP-C [24] . Inflammatory processes are non-specific contributors to cell death in neurodegenerative disorders such as Parkinson's disease (PD), Huntington disease, and NP-C disease [2, 18, 25] . It has been established that a broad class of host defense mediators, such as cytokines, can be secreted during the inflammatory reaction that accompanies several neurodegenerative progressive disorders and therefore neuroinflammatory mechanisms may account for the progressive neuronal degeneration that affects selected neuronal populations of the CNS [4, 37, 53] . Glial cells are one of the major cellular substrates of these cytotoxic mechanisms [2, 10, 18] . Some studies demonstrate that hUCB-MSCs secrete several immunomodulatory and neurotrophic factors that are likely to play a role in neuroprotection [21, 54] . In this study, we demonstrated that astrogliosis was reduced in hUCB-MSC transplanted NP-C mice as compared with the sham-transplanted group (Fig. 3B) . These results mean that transplanted hUCB-MSCs regulated the inflammatory reaction. The cytokine IL-10 has been shown to improve neurological symptoms after CNS injury [23] and to inhibit the synthesis of pro-inflammatory cytokines, including TNF- and IL-1 [6, 7, 22, 32, 33, 46] . Furthermore, IL-10 has been shown to slow down progression of apoptosis [1, 34] . Although there were no differences in expression of proinflammatory cytokines, we observed that the expression of IL-10 mRNA was increased in the cerebellum of the hUCB-MSC transplanted NP-C mice as compared with the shamtransplanted mice. These results represent that reduced apoptotic cells after the hUCB-MSC transplantation may have a relation, at least in part, with increased IL-10 expression by the hUCB-MSC treatment ( Fig. 2A) . Therefore, the effects of hUCB-MSCs on promoting the survival of Purkinje neurons is likely attributable to this cytokine.
Another interesting outcome of the present study was the reduction of cholesterol accumulation following hUCB-MSC transplantation (Fig. 3A) . Defective cholesterol transport is accepted as a hallmark of the cell-biological pathology in NP-C disease [52] . Thus, we examined whether hUCB-MSC treatment reduced the levels of cholesterol accumulation. The hUCB-MSC treatment of NP-C mice showed a significant decrease of cholesterol accumulation in the cerebellum. Although the exact mechanism of cholesterol accumulation has not been revealed in NP-C disease, recently studies have shown that increased sphingosine and decreased calcium in acidic organelles provoked the downstream storage of cholesterol and glycosphingolipids [26] . Our unpublished data have shown that MSCs could elevate acidic organelle calcium levels in NPC1 deficient cerebellar neurons. Based on these findings, we suggest that the inhibitory role of hUCB-MSCs in cholesterol accumulation has a connection with calcium modulation.
In conclusion, our results strongly suggest that hUCBMSCs transplantation promotes the survival of Purkinje neurons and inhibits cerebellar apoptotic cell death through modulation of the neuroinflammatory response. When taken together, this study provides that hUCB-MSCs are potential therapeutic agents against neurodegenerative diseases. Further studies are aimed at elucidating the molecu- 
